Loading
Latest filing published 03 Nov 2008 for HEMOBIOTECH INC, €101k.
No signal scores available.
All filings by Arthur Bollon on record concern Hemobiotech Inc. In total, 2 filings cover trades dated 30 October 2008.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 3 November 2008, the filings show an option exercise worth €101k in Hemobiotech Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations